Swiss National Bank’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.37M Buy
159,500
+3,100
+2% +$130K ﹤0.01% 1061
2026
Q1
$5.04M Buy
156,400
+1,200
+0.8% +$44.4K ﹤0.01% 1369
2025
Q4
$6.53M Buy
155,200
+3,400
+2% +$137K ﹤0.01% 1202
2025
Q3
$5.21M Buy
151,800
+2,900
+2% +$83.2K ﹤0.01% 1307
2025
Q2
$4.02M Sell
148,900
-1,300
-0.9% -$37.7K ﹤0.01% 1411
2025
Q1
$4.45M Sell
150,200
-900
-0.6% -$34.3K ﹤0.01% 1332
2024
Q4
$5.98M Buy
151,100
+1,800
+1% +$68.2K ﹤0.01% 1218
2024
Q3
$5.08M Buy
149,300
+3,100
+2% +$87.2K ﹤0.01% 1317
2024
Q2
$3.17M Buy
146,200
+2,800
+2% +$58.9K ﹤0.01% 1553
2024
Q1
$3.18M Hold
143,400
﹤0.01% 1585
2023
Q4
$3.94M Sell
143,400
-15,800
-10% -$381K ﹤0.01% 1433
2023
Q3
$3.55M Buy
159,200
+2,100
+1% +$54K ﹤0.01% 1488
2023
Q2
$4M Buy
157,100
+2,200
+1% +$53.3K ﹤0.01% 1446
2023
Q1
$3.45M Sell
154,900
-18,000
-10% -$435K ﹤0.01% 1494
2022
Q4
$4.1M Buy
172,900
+3,500
+2% +$81.3K ﹤0.01% 1443
2022
Q3
$2.81M Buy
169,400
+1,400
+0.8% +$31.5K ﹤0.01% 1640
2022
Q2
$3.34M Hold
168,000
﹤0.01% 1572
2022
Q1
$4.63M Buy
168,000
+12,200
+8% +$349K ﹤0.01% 1481
2021
Q4
$6.42M Buy
155,800
+7,200
+5% +$318K ﹤0.01% 1295
2021
Q3
$6.9M Buy
148,600
+900
+0.6% +$39.3K ﹤0.01% 1235
2021
Q2
$5.91M Sell
147,700
-1,400
-0.9% -$59.9K ﹤0.01% 1382
2021
Q1
$8.01M Buy
149,100
+20,900
+16% +$1.2M 0.01% 1133
2020
Q4
$6.27M Hold
128,200
﹤0.01% 1222
2020
Q3
$4.17M Buy
128,200
+22,800
+22% +$725K ﹤0.01% 1287
2020
Q2
$2.73M Buy
105,400
+15,400
+17% +$384K ﹤0.01% 1535
2020
Q1
$2.19M Buy
90,000
+2,000
+2% +$50.3K ﹤0.01% 1399
2019
Q4
$2.46M Buy
88,000
+17,400
+25% +$450K ﹤0.01% 1607
2019
Q3
$1.69M Buy
70,600
+9,400
+15% +$250K ﹤0.01% 1759
2019
Q2
$1.75M Buy
+61,200
New +$1.53M ﹤0.01% 1777

Other funds holding VCYT

Swiss National Bank's VCYT Position: Q2 2026 in Review

Swiss National Bank increased its Veracyte (VCYT) stake by 2% in Q2 2026, buying an estimated $130K and bringing the position to 159,500 shares worth $9.37M. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Swiss National Bank first reported a position in VCYT in Q2 2019 and has held it in 29 quarters since. 175 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

  • Swiss National Bank held 159,500 shares of Veracyte worth $9.37M as of Q2 2026.
  • Swiss National Bank bought 3,100 Veracyte shares in Q2 2026, an estimated $130K.
  • Veracyte made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1061 holding.
  • Swiss National Bank first reported a position in Veracyte in Q2 2019 and has held it in 29 quarters since.
  • 175 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.